Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 12Neoplasms 7cyclopia sequence 6Polycystic Ovary Syndrome 4Fatigue 4Obesity 3Multiple Myeloma 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms, Plasma Cell 2Hematologic Diseases 2Head and Neck Neoplasms 2Depression 2Weight Loss 1Warts 1Vomiting 1Vitamin D Deficiency 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Sleepiness 1Sezary Syndrome 1Prostatic Intraepithelial Neoplasia 1Primary Myelofibrosis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1

Interventions

Metformin 3Clomiphene 2Surveys and Questionnaires 1Sugars 1Diazoxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperinsulinism × Sugars × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡